UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of ADRB2 polymorphisms on response to longacting β2 -agonist therapy: a pharmacogenetic analysis of two randomised studies

The Lancet (British edition), 2007-12, Vol.370 (9605), p.2118-2125

2007

Volltextzugriff (PDF)

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species

The Journal of biological chemistry, 2004-10, Vol.279 (42), p.43940-43951

2004

Volltextzugriff (PDF)

Withdrawal: Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo : Role of mitochondrial reactive nitrogen species

The Journal of biological chemistry, 2019-09, Vol.294 (36), p.13525-13525

2019

Volltextzugriff (PDF)

ADRB2 Polymorphisms and Budesonide/Formoterol Responses in COPD

Chest, 2012-08, Vol.142 (2), p.320-328

2012

Volltextzugriff (PDF)

The Breathlessness, Cough, and Sputum Scale

Chest, 2003-12, Vol.124 (6), p.2182-2191

2003

Volltextzugriff (PDF)

Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo

The Journal of biological chemistry, 2004-10, Vol.279 (42), p.43940-43951

2004

Volltextzugriff (PDF)

The Breathlessness, Cough, and Sputum Scale: The development of empirically based guidelines for interpretation

Chest, 2003-12, Vol.124 (6), p.2182-2191

2003

Volltextzugriff (PDF)

Effect of ADRB2 polymorphisms on response to longacting [beta]^sub 2^-agonist therapy: a pharmacogenetic analysis of two randomised studies

The Lancet (British edition), 2007-12, Vol.370 (9605), p.2118

2007

Volltextzugriff (PDF)

Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection : AIDS clinical trials group study A5148

Antiviral therapy, 2006-01, Vol.11 (8), p.1081-1089

2006

Volltextzugriff (PDF)

Effect of ADRB2 polymorphisms on response to longacting β 2-agonist therapy: a pharmacogenetic analysis of two randomised studies

The Lancet (British edition), 2007, Vol.370 (9605), p.2118-2125

2007

Volltextzugriff (PDF)

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies

The Lancet (British edition), 2007-12, Vol.370 (9605), p.2118

2007

Volltextzugriff (PDF)

Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy : a pharmacogenetic analysis of two randomised studies. Commentary

The Lancet (British edition), 2007, Vol.370 (9605)

2007

Volltextzugriff (PDF)

Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers

Clinical transplantation, 2002-02, Vol.16 (1), p.1-8

2002

Volltextzugriff (PDF)

INFECTIOUS DISEASE PROPHYLAXIS IN RENAL TRANSPLANT PATIENTS: A SURVEY OF US TRANSPLANT CENTERS: Abstract# 846 Poster Board #-Session: P103-III

Transplantation, 2000-04, Vol.69 (Supplement), p.S331

2000

Volltextzugriff (PDF)

Treatment of Telangiectases

Vascular surgery, 1997-05, Vol.31 (3), p.261-264

1997

Volltextzugriff (PDF)

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)

Clinical cancer research, 2016-05, Vol.22 (10), p.2386-2395

2016

Volltextzugriff (PDF)

Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-04, Vol.372 (18), p.1700-1709

2015

Volltextzugriff (PDF)

PS01.66: Biomarker Stratification of Outcomes of Third-Generation EGFR TKI Therapy in Patients with Previously-Treated Advanced NSCLC: Topic: Medical Oncology

Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S311-S312

2016

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) genotyping of matched urine, plasma and tumor tissue from non-small cell lung cancer (NSCLC) patients (pts) treated with rociletinib

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9001-9001

2016

Volltextzugriff (PDF)

MA08.01 A Highly Sensitive Next-Generation Sequencing Platform for Detection of NSCLC EGFR T790M Mutation in Urine and Plasma

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S384-S385

2017

Volltextzugriff (PDF)

Abstract 927: Pretreatment and serial plasma assessments of EGFR mutations in NSCLC patients treated with rociletinib (CO-1686)

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.927-927

2015

Volltextzugriff (PDF)

PS01.66: Biomarker Stratification of Outcomes of Third-Generation EGFR TKI Therapy in Patients with Previously-Treated Advanced NSCLC

Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S311-S312

2016

Volltextzugriff (PDF)

Abstract B136: Plasma EGFR mutation detection using a combined exosomal RNA and circulating tumor DNA approach in patients with acquired resistance to first-generation EGFR-TKIs

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.B136-B136

2015

Volltextzugriff (PDF)

Abstract 5587: Serial monitoring of EGFR mutations in plasma and evaluation of EGFR mutation status in matched tissue and plasma from NSCLC patients treated with CO-1686

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5587-5587

2014

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(29)
Zeitungsartikel
(13)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of ADRB2 polymorphisms on response to longacting β2 -agonist therapy: a pharmacogenetic analysis of two randomised studies

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species

Withdrawal: Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo : Role of mitochondrial reactive nitrogen species

ADRB2 Polymorphisms and Budesonide/Formoterol Responses in COPD

The Breathlessness, Cough, and Sputum Scale

Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo

The Breathlessness, Cough, and Sputum Scale: The development of empirically based guidelines for interpretation

Effect of ADRB2 polymorphisms on response to longacting [beta]^sub 2^-agonist therapy: a pharmacogenetic analysis of two randomised studies

Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection : AIDS clinical trials group study A5148

Effect of ADRB2 polymorphisms on response to longacting β 2-agonist therapy: a pharmacogenetic analysis of two randomised studies

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies

Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy : a pharmacogenetic analysis of two randomised studies. Commentary

Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers

INFECTIOUS DISEASE PROPHYLAXIS IN RENAL TRANSPLANT PATIENTS: A SURVEY OF US TRANSPLANT CENTERS: Abstract# 846 Poster Board #-Session: P103-III

Treatment of Telangiectases

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)

Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

PS01.66: Biomarker Stratification of Outcomes of Third-Generation EGFR TKI Therapy in Patients with Previously-Treated Advanced NSCLC: Topic: Medical Oncology

Epidermal growth factor receptor (EGFR) genotyping of matched urine, plasma and tumor tissue from non-small cell lung cancer (NSCLC) patients (pts) treated with rociletinib

EGFR Genotyping of Matched Urine, Plasma, and Tumor Tissue in Patients With Non–Small-Cell Lung Cancer Treated With Rociletinib, an EGFR Tyrosine Kinase Inhibitor

MA08.01 A Highly Sensitive Next-Generation Sequencing Platform for Detection of NSCLC EGFR T790M Mutation in Urine and Plasma

Abstract 927: Pretreatment and serial plasma assessments of EGFR mutations in NSCLC patients treated with rociletinib (CO-1686)

PS01.66: Biomarker Stratification of Outcomes of Third-Generation EGFR TKI Therapy in Patients with Previously-Treated Advanced NSCLC

Abstract B136: Plasma EGFR mutation detection using a combined exosomal RNA and circulating tumor DNA approach in patients with acquired resistance to first-generation EGFR-TKIs

Abstract 5587: Serial monitoring of EGFR mutations in plasma and evaluation of EGFR mutation status in matched tissue and plasma from NSCLC patients treated with CO-1686

Suchergebnisse filtern